Similar Papers

Paper Title
Journal
Date
Author
#4844 BELIMUMAB AND MULTITARGET THERAPY AS INDUCTION THERAPY OF SEVERE ACTIVE LUPUS NEPHRITIS: CASE SERIES FROM CHINA
Min Min ... Jiong Zhang
Nephrology Dialysis Transplantation | VOL. 38
Min Min, et. al.Min Min ... Jiong Zhang
14 Jun 2023
A Study on Clinical and Laboratory Status of Active and Inactive LN Patients
Muhammad Anamul Hoque ... Monika Roy
Saudi Journal of Medical and Pharmaceutical Sciences | VOL. 9
Muhammad Anamul Hoque, et. al.Muhammad Anamul Hoque ... Monika Roy
23 Jun 2023
The Use of Serological Tests in the Care of Patients with Lupus Nephritis.
Isabelle Ayoub ... Brad H Rovin
Clinical journal of the American Society of Nephrology : CJASN | VOL. 17
Isabelle Ayoub, et. al.Isabelle Ayoub ... Brad H Rovin
01 Feb 2022
POS1430 EPIDEMIOLOGY OF LUPUS NEPHRITIS IN BRAZIL: FINDINGS FROM THE MACUNAÍMA STUDY - A NATIONWIDE MULTICENTRIC STUDY
M Abreu ... F Dos Santos Beserra
-
M Abreu, et. al.M Abreu ... F Dos Santos Beserra
19 May 2021
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the rheumatic diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
20 Dec 2024
2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the Rheumatic Diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
19 Dec 2024
Contents
-
Annals of the Rheumatic Diseases | VOL. 83
--
01 Dec 2024
Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults
Elizabeth M Winter ... Anne T Leerling
Annals of the Rheumatic Diseases | VOL. -
Elizabeth M Winter, et. al.Elizabeth M Winter ... Anne T Leerling
28 Nov 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.